|
Ontario, Canada
|
|
98-1220792
|
(State or other jurisdiction of incorporation or organization)
|
|
(IRS Employer Identification No.)
|
|
|
|
895 Don Mills Road, Bldg. 2, Suite 900
|
|
|
Toronto, Ontario, Canada, M3C 1W3
|
|
|
(Address of principal executive offices)
|
|
|
Title of Each Class
|
Trading Symbol(s)
|
Name of Each Exchange on Which Registered
|
Common Shares
|
ANY
|
NASDAQ Capital Market
|
|
|
|
|
|||
|
|
|
|
|
Item 1.
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
Item 2.
|
|
|
||
|
|
|
|
|
Item 3.
|
|
|
||
|
|
|
|
|
Item 4.
|
|
|
||
|
|
|
|
|
|
|
|||
|
|
|
|
|
Item 1.
|
|
|
||
|
|
|
|
|
Item 1A.
|
|
|
||
|
|
|
|
|
Item 2.
|
|
|
||
|
|
|
|
|
Item 3.
|
|
|
||
|
|
|
|
|
Item 4.
|
|
|
||
|
|
|
|
|
Item 5.
|
|
|
||
|
|
|
|
|
Item 6.
|
|
|
||
|
|
|
|
|
|
|
|
|
Three Months
Ended March 31, |
||||||
|
2020
|
|
2019
|
||||
|
|
|
|
||||
|
(Unaudited)
|
||||||
Revenue
|
$
|
1,010
|
|
|
$
|
2,130
|
|
Cost of revenue
|
547
|
|
|
1,435
|
|
||
Gross profit
|
463
|
|
|
695
|
|
||
Operating expenses:
|
|
|
|
||||
Sales and marketing
|
304
|
|
|
453
|
|
||
Research and development
|
339
|
|
|
697
|
|
||
General and administrative
|
984
|
|
|
1,252
|
|
||
|
1,627
|
|
|
2,402
|
|
||
Loss from operations
|
(1,164
|
)
|
|
(1,707
|
)
|
||
Other income (expense):
|
|
|
|
||||
Interest expense, related party
|
—
|
|
|
(142
|
)
|
||
Interest expense
|
(9
|
)
|
|
(3
|
)
|
||
Other income, net
|
70
|
|
|
8
|
|
||
Net loss
|
(1,103
|
)
|
|
(1,844
|
)
|
||
Net loss per share:
|
|
|
|
||||
Basic and diluted
|
$
|
(0.28
|
)
|
|
$
|
(0.82
|
)
|
Shares used in computing net loss per share:
|
|
|
|
||||
Basic and diluted
|
3,947,657
|
|
|
2,236,590
|
|
|
Three Months
Ended March 31, |
||||||
|
2020
|
|
2019
|
||||
|
|
|
|
||||
|
(Unaudited)
|
||||||
Net loss
|
$
|
(1,103
|
)
|
|
$
|
(1,844
|
)
|
Other comprehensive (loss) income:
|
|
|
|
||||
Foreign currency translation adjustment
|
(71
|
)
|
|
40
|
|
||
Total other comprehensive (loss) income
|
(71
|
)
|
|
40
|
|
||
Comprehensive loss
|
$
|
(1,174
|
)
|
|
$
|
(1,804
|
)
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
|
|
|
|
||||
Assets
|
(Unaudited)
|
||||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
285
|
|
|
$
|
149
|
|
Accounts receivable, net
|
335
|
|
|
369
|
|
||
Inventories
|
694
|
|
|
753
|
|
||
Other current assets
|
666
|
|
|
670
|
|
||
Total current assets
|
1,980
|
|
|
1,941
|
|
||
Investment in affiliate
|
2,100
|
|
|
2,100
|
|
||
Intangible assets, net
|
1,976
|
|
|
2,301
|
|
||
Goodwill
|
1,385
|
|
|
1,385
|
|
||
Other assets
|
616
|
|
|
679
|
|
||
Total assets
|
$
|
8,057
|
|
|
$
|
8,406
|
|
Liabilities and Shareholders’ Equity
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
4,151
|
|
|
$
|
4,113
|
|
Accrued liabilities
|
659
|
|
|
475
|
|
||
Accrued payroll and employee compensation
|
339
|
|
|
340
|
|
||
Deferred revenue
|
914
|
|
|
1,069
|
|
||
Line of credit
|
491
|
|
|
491
|
|
||
Other current liabilities
|
196
|
|
|
158
|
|
||
Total current liabilities
|
6,750
|
|
|
6,646
|
|
||
Deferred revenue, long-term
|
365
|
|
|
485
|
|
||
Convertible debt
|
375
|
|
|
—
|
|
||
Convertible debt-related party
|
350
|
|
|
—
|
|
||
Other non-current liabilities
|
16
|
|
|
35
|
|
||
Total liabilities
|
7,856
|
|
|
7,166
|
|
||
Commitments and contingencies (Note 13)
|
|
|
|
|
|
||
Shareholders’ equity:
|
|
|
|
||||
Preferred shares, no par value, unlimited shares authorized, 8,443,778 shares issued and outstanding at both March 31, 2020 and December 31, 2019
|
8,444
|
|
|
8,444
|
|
||
Common shares, no par value; unlimited shares authorized, 4,016,825 and 3,850,105 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively
|
186,296
|
|
|
186,161
|
|
||
Accumulated other comprehensive loss
|
(1,840
|
)
|
|
(1,769
|
)
|
||
Accumulated deficit
|
(192,699
|
)
|
|
(191,596
|
)
|
||
Total shareholders’ equity
|
201
|
|
|
1,240
|
|
||
Total liabilities and shareholders’ equity
|
$
|
8,057
|
|
|
$
|
8,406
|
|
|
Three Months
Ended March 31, |
||||||
|
2020
|
|
2019
|
||||
|
|
|
|
||||
Operating activities:
|
(Unaudited)
|
||||||
Net loss
|
$
|
(1,103
|
)
|
|
$
|
(1,844
|
)
|
Adjustments to reconcile net loss to cash used in operating activities:
|
|
|
|
||||
Depreciation and amortization
|
247
|
|
|
267
|
|
||
Share-based compensation
|
5
|
|
|
124
|
|
||
Preferred shares interest expense-related party
|
—
|
|
|
130
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
||||
Accounts receivable
|
34
|
|
|
282
|
|
||
Inventories
|
59
|
|
|
(16
|
)
|
||
Accounts payable and accrued liabilities
|
363
|
|
|
70
|
|
||
Accrued payroll and employee compensation
|
8
|
|
|
(62
|
)
|
||
Deferred revenue
|
(276
|
)
|
|
(191
|
)
|
||
Other assets and liabilities, net
|
224
|
|
|
250
|
|
||
Net cash used in operating activities
|
(439
|
)
|
|
(990
|
)
|
||
Financing activities:
|
|
|
|
||||
Proceeds from convertible debt
|
375
|
|
|
—
|
|
||
Proceeds from convertible debt-related party
|
200
|
|
|
—
|
|
||
Proceeds from debt - related party
|
—
|
|
|
523
|
|
||
Proceeds from line of credit, net
|
—
|
|
|
265
|
|
||
Net cash provided by financing activities
|
575
|
|
|
788
|
|
||
Net increase (decrease) in cash and cash equivalents
|
136
|
|
|
(202
|
)
|
||
Cash and cash equivalents, beginning of period
|
149
|
|
|
341
|
|
||
Cash and cash equivalents, end of period
|
$
|
285
|
|
|
$
|
139
|
|
Supplemental disclosures of cash flow information:
|
|
|
|
||||
Cash paid for interest
|
$
|
32
|
|
|
$
|
10
|
|
Supplemental disclosures of non-cash financing activities:
|
|
|
|
||||
Issuance of convertible debt-related party for prepaid business advisory services
|
$
|
150
|
|
|
$
|
—
|
|
Issuance of common shares for settlement of liabilities
|
$
|
130
|
|
|
$
|
—
|
|
Issuance of common shares for settlement of related party liabilities
|
$
|
—
|
|
|
$
|
105
|
|
|
Preferred Shares
|
|
Common Shares
|
|
Accumulated
Other Comprehensive Loss |
|
Accumulated
Deficit |
|
Total
Shareholders' Equity |
||||||||||||||||
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|||||||||||||||||
Balance at January 1, 2020
|
8,443,778
|
|
|
$
|
8,444
|
|
|
3,850,105
|
|
|
$
|
186,161
|
|
|
$
|
(1,769
|
)
|
|
$
|
(191,596
|
)
|
|
$
|
1,240
|
|
Issuance of common shares pursuant to
the vesting of restricted stock units
|
—
|
|
|
—
|
|
|
20,420
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Issuance of restricted stock awards for the
settlement of liabilities
|
—
|
|
|
—
|
|
|
146,300
|
|
|
130
|
|
|
—
|
|
|
—
|
|
|
130
|
|
|||||
Share-based compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
5
|
|
|
—
|
|
|
—
|
|
|
5
|
|
|||||
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(71
|
)
|
|
—
|
|
|
(71
|
)
|
|||||
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,103
|
)
|
|
(1,103
|
)
|
|||||
Balance at March 31, 2020
|
8,443,778
|
|
|
$
|
8,444
|
|
|
4,016,825
|
|
|
$
|
186,296
|
|
|
$
|
(1,840
|
)
|
|
$
|
(192,699
|
)
|
|
$
|
201
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Preferred Shares
|
|
Common Shares
|
|
Accumulated
Other Comprehensive Loss |
|
Accumulated
Deficit |
|
Total
Shareholders' Deficit |
||||||||||||||||
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|||||||||||||||||
Balance at January 1, 2019
|
—
|
|
|
$
|
—
|
|
|
2,219,141
|
|
|
$
|
183,524
|
|
|
$
|
(1,816
|
)
|
|
$
|
(187,315
|
)
|
|
$
|
(5,607
|
)
|
Issuance of common shares pursuant to
the vesting of restricted stock units |
—
|
|
|
—
|
|
|
38,930
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Issuance of restricted stock awards for the
settlement of liabilities |
—
|
|
|
—
|
|
|
42,000
|
|
|
105
|
|
|
—
|
|
|
—
|
|
|
105
|
|
|||||
Share-based compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
124
|
|
|
—
|
|
|
—
|
|
|
124
|
|
|||||
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
40
|
|
|
—
|
|
|
40
|
|
|||||
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,844
|
)
|
|
(1,844
|
)
|
|||||
Balance at March 31, 2019
|
—
|
|
|
$
|
—
|
|
|
2,300,071
|
|
|
$
|
183,753
|
|
|
$
|
(1,776
|
)
|
|
$
|
(189,159
|
)
|
|
$
|
(7,182
|
)
|
1.
|
Organization and Business
|
2.
|
Significant Accounting Policies
|
3.
|
Certain Balance Sheet Items
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
Raw materials
|
$
|
124
|
|
|
$
|
92
|
|
Work in process
|
165
|
|
|
137
|
|
||
Finished goods
|
405
|
|
|
524
|
|
||
|
$
|
694
|
|
|
$
|
753
|
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
Transition service agreement
|
$
|
168
|
|
|
$
|
345
|
|
Deferred cost - service contracts
|
115
|
|
|
118
|
|
||
Prepaid insurance and services
|
378
|
|
|
207
|
|
||
Other
|
5
|
|
|
—
|
|
||
|
$
|
666
|
|
|
$
|
670
|
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
Prepaid insurance and services
|
$
|
486
|
|
|
$
|
519
|
|
Deferred cost – service contracts
|
125
|
|
|
154
|
|
||
Other
|
5
|
|
|
6
|
|
||
|
$
|
616
|
|
|
$
|
679
|
|
4.
|
Intangible Assets
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
Developed technology
|
$
|
13,323
|
|
|
$
|
13,323
|
|
Channel partner relationships
|
730
|
|
|
730
|
|
||
Capitalized development costs(1)
|
2,779
|
|
|
3,047
|
|
||
Customer relationships
|
380
|
|
|
380
|
|
||
|
17,212
|
|
|
17,480
|
|
||
Accumulated amortization:
|
|
|
|
||||
Developed technology
|
(12,803
|
)
|
|
(12,682
|
)
|
||
Channel partner relationships
|
(385
|
)
|
|
(355
|
)
|
||
Capitalized development costs(1)
|
(1,997
|
)
|
|
(2,094
|
)
|
||
Customer relationships
|
(331
|
)
|
|
(328
|
)
|
||
|
(15,516
|
)
|
|
(15,459
|
)
|
||
Total finite-lived assets, net
|
1,696
|
|
|
2,021
|
|
||
Indefinite-lived intangible assets - trade names
|
280
|
|
|
280
|
|
||
Total intangible assets, net
|
$
|
1,976
|
|
|
$
|
2,301
|
|
(1)
|
Includes the impact of foreign currency exchange rate fluctuations.
|
5.
|
Investment in Affiliate
|
6.
|
Debt
|
7.
|
Fair Value Measurements
|
8.
|
Preferred Shares
|
9.
|
Share Capital
|
Date issued
|
|
Contractual life (years)
|
|
Exercise price
|
|
Number outstanding
|
|
Expiration
|
|
May 2015
|
|
5
|
|
$800.00
|
|
4,200
|
|
|
May 31, 2020
|
October 2015
|
|
5
|
|
$466.00
|
|
2,010
|
|
|
October 14, 2020
|
December 2015
|
|
5
|
|
$500.00
|
|
5,138
|
|
|
December 15, 2020
|
December 2015
|
|
5
|
|
$216.00
|
|
7,500
|
|
|
December 4, 2020
|
March 2016
|
|
5
|
|
$500.00
|
|
150
|
|
|
March 4, 2021
|
August 2017
|
|
5
|
|
$42.00
|
|
37,500
|
|
|
August 11, 2022
|
August 2017
|
|
5
|
|
$42.00
|
|
11,876
|
|
|
August 16, 2022
|
August 2017
|
|
5
|
|
$42.00
|
|
25,625
|
|
|
August 22, 2022
|
April 2018
|
|
5
|
|
$5.60
|
|
111,563
|
|
|
April 17, 2023
|
March 2020
|
|
3
|
|
$0.60
|
|
1,205,820
|
|
|
March 23, 2023
|
|
|
|
|
|
|
1,411,382
|
|
(1)
|
|
(1)
|
Includes warrants to purchase up to 628,320 common shares, in the aggregate, outstanding to related parties at March 31, 2020.
|
10.
|
Equity Incentive Plans
|
|
|
Three Months
Ended March 31, |
||||||
|
|
2020
|
|
2019
|
||||
Cost of sales
|
|
$
|
—
|
|
|
$
|
693
|
|
Sales and marketing
|
|
2,014
|
|
|
10,313
|
|
||
Research and development
|
|
2,532
|
|
|
18,471
|
|
||
General and administrative
|
|
—
|
|
|
94,565
|
|
||
Total share-based compensation expense
|
|
$
|
4,546
|
|
|
$
|
124,042
|
|
11.
|
Net Loss per Share
|
|
Three Months
Ended March 31, |
||||
|
2020
|
|
2019
|
||
Common share purchase warrants
|
1,411,382
|
|
|
205,687
|
|
Convertible debt
|
1,116,500
|
|
|
—
|
|
Restricted stock not yet vested or released
|
—
|
|
|
114,066
|
|
Options outstanding
|
1,175
|
|
|
10,298
|
|
12.
|
Related Party Transactions
|
13.
|
Commitments and Contingencies
|
|
Deferred
Revenue |
||
Liability at January 1, 2020
|
$
|
1,109
|
|
Settlements made during the period
|
(271
|
)
|
|
Change in liability for warranties issued during the period
|
119
|
|
|
Change in liability for pre-existing warranties
|
—
|
|
|
Liability at March 31, 2020
|
$
|
957
|
|
Current liability
|
593
|
|
|
Non-current liability
|
364
|
|
|
Liability at March 31, 2020
|
$
|
957
|
|
14.
|
Subsequent Events
|
•
|
On June 1, 2020, the Company entered into a consulting agreement with GROUPE PARAMEUS CORP (“GROUPE P”) to provide consulting services for one year to the Company in the area of corporate finance, investor communications and financial and investor public relations. As compensation for GROUPE P’s services to be provided pursuant to the consulting agreement, in addition to a prepayment of $150,000 in cash, the Company granted 100,000 restricted stock awards, 100,000 common shares of the Company pursuant to the terms of Regulation D under the Securities Act of 1933, and a non-qualified stock option for the purchase of 50,000 common shares at an exercise price of $2.52 per share with a vest period over six months. On June 16, 2020, the Company issued 200,000 common shares to GROUPE P with a fair value of $504,000.
|
•
|
In the second quarter of 2020, the Company entered into various other consulting agreements for business advisory services. On June 16, 2020, the Company granted 130,000 of restricted stock awards and issued 130,000 common shares of the Company with a fair value of $327,000 in lieu of cash payment to certain business advisors for future services to be performed. The Company granted to the same business advisors, in the aggregate, non-qualified stock options for the purchase of 80,000 common shares with an exercise price of $2.52 per share for future services to be performed for the Company.
|
•
|
On May 15, 2020, the Company entered into an equity purchase agreement and registration rights agreement with Oasis Capital, LLC (“Oasis Capital”), to purchase from the Company up to $11.0 million common shares of the Company. Under the purchase agreement, the Company has the right to sell up to $11.0 million of its common shares to Oasis Capital over a 36-month period, upon satisfaction of the conditions in the Agreement, including the effectiveness of a resale registration statement being filed on Form S-1. The Company will control the timing and amount of any sales to Oasis Capital, and Oasis Capital is obligated to make purchases in accordance with the purchase agreement, upon certain terms and conditions being met. The purchase agreement, which contains a floor price of $1.58 per common share, allows the Company to fund its needs in a more expedient and cost-effective manner, on the pricing terms set forth in the purchase agreement. The equity line is designed to provide capital to the company as it is required.
|
•
|
On May 6, 2020, the Company filed articles of amendment to create a fourth series of preferred shares, being, an unlimited number of Series D Preferred Shares and to provide for the rights, privileges, restrictions and conditions attaching thereto. The Series D Preferred Shares are convertible into our common shares, at a conversion price equal to $0.65, subject to certain anti-dilution adjustments. Each shareholder of the Series D Preferred Shares, may, at any time, convert all or any part of the Series D Preferred Shares provided that after such conversion the common shares issuable, together with all the common shares held by the shareholder in the aggregate would not exceed 9.9% of the total number of outstanding common shares of the Company or in the aggregate no more than 800,000 common shares by all holders of Series D Preferred Shares. The Series D Preferred Shares do not have voting rights.
|
•
|
On April 30, 2020, the Company entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with two investors (the “Purchasers“) relating to the issuance and sale, in the aggregate, of 1,694,000 shares (the “Shares“) of the Company's subsequently established Series D Convertible Preferred Shares, no par value and warrants to purchase up to 1,694,000 common shares of the Company in a private placement transaction, in exchange for the assignment to the Company by the investors of certain promissory notes receivable held by the investors in an aggregate amount of $1.1 million. Subject to certain limitations, the warrants will be exercisable commencing on the six month anniversary at an exercise price equal to $0.92 per common share, subject to adjustments as provided under the terms of the warrants, and are exercisable for a five years period. The warrants include a provision restricting the warrant holder from exercising it if the aggregate number of common shares held by the warrant holder equals or exceeds 5.0% of the issued and outstanding shares of the Company, calculated on a partially converted basis (i.e., assuming the conversion of all rights to receive common shares of the Company held by the warrant holder). On May 25, 2020, the Company converted 450,000 shares of the Series D Preferred Shares and issued 450,000 common shares of the Company. As a result of the conversion, one of the Purchasers, Gora Consulting Corp. (“Gora”) is classified as a related party to the Company. Gora participated in the Securities Purchase Agreement by acquiring 847,000 Shares and warrants to purchase 847,000 common shares, in exchange for the assignment to the Company certain promissory notes receivable held by Gora in an aggregate amount of $550,000. On May 25, 2020, Gora was issued 225,000 common shares. In addition, on April 21, 2020, the sole owner of Gora entered into a share purchase agreement with an employee of the Company and acquired 211,745 common shares of the Company.
|
•
|
On April 24, 2020, the Company entered into a consulting agreement (the “ROK Consulting Agreement”) with ROK Consulting Inc. (“ROK”) to provide consulting services to the Company in the area of corporate finance, investor communications and financial and investor public relations. As compensation for ROK’s services to be provided pursuant to the ROK Consulting Agreement, in addition to cash compensation, the Company has agreed to issue to ROK 375,000 common shares of the Company, 150,000 of such shares were due at signing of the ROK Consulting Agreement, while the remaining 225,000 shares are to be issued upon the completion of the three month term of the ROK Consulting Agreement. On June 19, 2020, the Company issued 150,000 common shares of the Company to ROK with a fair value of $360,000 per the terms of the ROK Consulting Agreement.
|
•
|
On April 21, 2020, two investors entered into share purchase agreements to acquire in the aggregate 330,000 common shares of the Company. As a result of this transaction, 1542082 Ontario Limited (“1542082 Ontario”), an investor participating in the March 23, 2020 offering, will hold enough common shares of the Company be classified as a related party. 1542082 Ontario acquired 120,000 common shares of the Company in this transaction. In March 2020, 1542082 Ontario, paid directly $150,000 to a business advisor on the behalf of the Company for a prepayment of future services to the Company.
|
•
|
Between April 7, 2020 and April 24, 2020, the Company converted $377,000 of convertible debt and issued 580,580 common shares of the Company, of which $176,000 of debt converted was held by related parties, and they were issued in the aggregate 271,040 common shares.
|
•
|
On April 9, 2020, the Company received loan proceeds in the amount of $667,400 (the “PPP Funds”) and entered into a loan agreement with City National Bank pursuant to the CARES Act. The CARES Act was established in order to enable small businesses to pay employees during the economic slowdown caused by COVID-19 by providing forgivable loans to qualifying businesses for up to 2.5 times their average monthly payroll costs. The amount borrowed by the Company under the CARES Act is eligible to be forgiven provided that (a) the Company uses the PPP Funds during the eight week period after receipt thereof, and (b) the PPP Funds are only used to cover payroll costs (including benefits), rent, mortgage interest, and utility costs. The amount of loan forgiveness will be reduced if, among other reasons, the Company does not maintain staffing or payroll levels. Principal and interest payments on any unforgiven portion of the PPP Funds (the “PPP Loan”) will be deferred for six months and will accrue interest at a fixed annual rate of 1.0% and carry a two year maturity date. There is no prepayment penalty on the CARES Act Loan.
|
•
|
On February 13, 2020, the Company entered into a business advisory agreement with Torrington Financial Services Ltd (“Torrington”), a financial adviser to the Company. As a result of the March 23, 2020 transaction, Torrington and its entity under common control, Lallande Poydras Investment Partnership (“Lallande”), both participated in the below offering and are classified as a related party of the Company. On March 23, 2020, the Company entered into subscription agreements by and among the Company and the investors party thereto, including Torrington and Lallande, for the purchase and sale of 725 units (collectively, the “Units” and individually, a “Unit”) for aggregate gross proceeds of $725,000 with each Unit consisting of (a) a 6.0% convertible debenture in the principal amount of $1,000, which is convertible at $0.6495 per share into 1,540 common shares of the Company, and (b) a warrant to purchase 1,540 common shares of the Company exercisable at any time on or before the third year anniversary date at an exercise price of $0.60 per share. The warrant includes a provision restricting the warrant holder from exercising it if the aggregate number of common shares held by the warrant holder equals or exceeds 5.0% of the issued and outstanding shares of the Company, calculated on a partially converted basis (i.e., assuming the conversion of all rights to receive common shares of the Company held by the warrant holder). Torrington and Lallande participated in the offering and in the aggregate purchased 200 units, as well as for compensation for Torrington’s services, the Company issued to Torrington convertible debentures equal to $58,000 and convertible into 89,320 common shares and a warrant for the purchase of 89,320 shares, with other terms substantially the same as the investors. The Company received cash proceeds of $575,000 from the offering, and a participant of the offering paid directly $150,000 to a financial consultant for a prepayment of future services to the Company. The Company intends to use the remaining proceeds from the offering for general corporate and working capital purposes.
|
|
Three Months
Ended March 31, |
||||
|
2020
|
|
2019
|
||
Revenue
|
100.0
|
%
|
|
100.0
|
%
|
Cost of revenue
|
54.2
|
|
|
67.4
|
|
Gross profit
|
45.8
|
|
|
32.6
|
|
Operating expenses:
|
|
|
|
|
|
Sales and marketing
|
30.1
|
|
|
21.3
|
|
Research and development
|
33.6
|
|
|
32.7
|
|
General and administrative
|
97.4
|
|
|
58.8
|
|
|
161.1
|
|
|
112.8
|
|
Loss from operations
|
(115.3
|
)
|
|
(80.2
|
)
|
Interest expense
|
(0.9
|
)
|
|
(6.8
|
)
|
Other income, net
|
6.9
|
|
|
0.4
|
|
Net loss
|
(109.3
|
)
|
|
(86.6
|
)
|
|
|
Three Months
Ended March 31, |
|
|
|||||||
|
|
2020
|
|
2019
|
|
Change
|
|||||
Gross profit
|
|
$
|
463
|
|
|
$
|
695
|
|
|
(33.4
|
)%
|
Gross margin
|
|
45.8
|
%
|
|
32.6
|
%
|
|
40.5
|
%
|
|
|
Maturity Date
|
|
Interest Rate
|
|
Amount Outstanding
|
||
Convertible debt
|
|
3/23/2023
|
|
6.0%
|
|
$
|
725
|
|
Line of credit
|
|
9/19/2020
|
|
6.5%
|
|
$
|
491
|
|
|
|
Three Months
Ended March 31, |
||||||
|
|
2020
|
|
2019
|
||||
Net cash used in operating activities
|
|
$
|
(439
|
)
|
|
$
|
(990
|
)
|
Net cash used in investing activities
|
|
$
|
—
|
|
|
$
|
—
|
|
Net cash provided by financing activities
|
|
$
|
575
|
|
|
$
|
788
|
|
Item 1.
|
Legal Proceedings.
|
Exhibit
|
|
Filed
|
Incorporated by Reference
|
||
Number
|
Description
|
Herewith
|
Form
|
File No.
|
Date Filed
|
|
|
|
|
|
|
3.1
|
|
6-K
|
001-36532
|
3/25/2015
|
|
|
|
|
|
|
|
3.2
|
|
6-K
|
001-36532
|
7/17/2017
|
|
|
|
|
|
|
|
3.3
|
|
8-K
|
001-36532
|
10/2/2018
|
|
|
|
|
|
|
|
3.4
|
|
8-K
|
001-36532
|
10/5/2018
|
|
|
|
|
|
|
|
3.5
|
|
8-K
|
001-36532
|
11/5/2018
|
|
|
|
|
|
|
|
3.6
|
|
8-K
|
001-36532
|
11/14/2018
|
|
|
|
|
|
|
|
3.7
|
|
8-K
|
001-36532
|
7/12/2019
|
|
|
|
|
|
|
|
3.8
|
|
8-K
|
001-36532
|
11/8/2019
|
|
|
|
|
|
|
|
3.9
|
|
8-K
|
001-36532
|
5/8/2020
|
|
|
|
|
|
|
|
3.10
|
|
6-K
|
001-36532
|
7/17/2017
|
|
|
|
|
|
|
|
3.11
|
|
6-K
|
001-36532
|
5/12/2017
|
|
|
|
|
|
|
|
4.1
|
|
8-K
|
001-36532
|
3/27/2020
|
|
|
|
|
|
|
|
4.2
|
|
8-K
|
001-36532
|
3/27/2020
|
|
|
|
|
|
|
|
4.3
|
|
8-K
|
001-36532
|
5/4/2020
|
|
|
|
|
|
|
|
10.1
|
|
8-K
|
001-36532
|
3/27/2020
|
|
|
|
|
|
|
|
10.2
|
|
8-K
|
001-36532
|
5/4/2020
|
|
|
|
|
|
|
|
10.3
|
|
10-K
|
001-36532
|
5/14/2020
|
|
|
|
|
|
|
|
10.4
|
|
10-K
|
001-36532
|
5/14/2020
|
|
|
|
|
|
|
|
10.5
|
|
10-K
|
001-36532
|
5/14/2020
|
|
|
|
|
|
|
|
10.6
|
|
8-K
|
001-36532
|
5/19/2020
|
|
|
|
|
|
|
|
10.7
|
|
8-K
|
001-36532
|
5/19/2020
|
|
|
|
|
|
|
|
10.8
|
|
S-1
|
333-238531
|
5/20/2020
|
|
|
|
|
|
|
|
Exhibit
|
|
Filed
|
Incorporated by Reference
|
||
Number
|
Description
|
Herewith
|
Form
|
File No.
|
Date Filed
|
10.9
|
X
|
|
|
|
|
|
|
|
|
|
|
10.10
|
X
|
|
|
|
|
|
|
|
|
|
|
10.11
|
X
|
|
|
|
|
|
|
|
|
|
|
10.12
|
X
|
|
|
|
|
|
|
|
|
|
|
31.1
|
X
|
|
|
|
|
|
|
|
|
|
|
31.2
|
X
|
|
|
|
|
|
|
|
|
|
|
32
|
X
|
|
|
|
|
|
|
|
|
|
|
101.INS
|
XBRL Instance Document
|
X
|
|
|
|
|
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema
|
X
|
|
|
|
|
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Presentation Linkbase
|
X
|
|
|
|
|
|
|
Sphere 3D Corp.
|
|
|
|
|
|
|
Date:
|
June 24, 2020
|
|
By:
|
/s/ Peter Tassiopoulos
|
|
|
|
|
Peter Tassiopoulos
Chief Executive Officer
(Principal Executive Officer)
|
COMPANY:
|
|
Sphere 3D Corp.
|
|
By:
|
/s/ Peter Tassiopoulos
|
Name:
Title:
|
Peter Tassiopoulos
CEO
|
|
|
INVESTOR:
|
|
Oasis Capital, LLC
|
|
By:
|
/s/ Adam Long
|
Name:
Title:
|
Adam Long
Managing Partner
|
Sphere 3D Corp.
/s/ Peter Tassiopoulos
Name: Peter Tassiopoulos
Title: CEO
|
GROUPE PARAMEUS CORP.
/s/ Samuel Kafkas
Name:
Title: President
|
a.
|
Advise and assist the company in developing and implementing appropriate plans and materials for presenting the Company and its business plan, strategy and personnel to the financial community.
|
b.
|
With the cooperation of the Company, maintain an awareness during the term of the agreement of the Company’s plan’s and strategy as it relates to the financial community.
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Sphere 3D Corp.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report;
|
4.
|
The company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:
|
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
(c)
|
Evaluated the effectiveness of the issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
(d)
|
Disclosed in this report any change in the issuer’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the issuer’s internal control over financial reporting; and
|
5.
|
The company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer’s auditors and the audit committee of the issuer’s board of directors (or persons performing the equivalent functions):
|
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer’s ability to record, process, summarize and report financial information; and
|
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer’s internal control over financial reporting.
|
/s/ Peter Tassiopoulos
|
Peter Tassiopoulos
|
Chief Executive Officer
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Sphere 3D Corp.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report;
|
4.
|
The company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:
|
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
(c)
|
Evaluated the effectiveness of the issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
(d)
|
Disclosed in this report any change in the issuer’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the issuer’s internal control over financial reporting; and
|
5.
|
The company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer’s auditors and the audit committee of the issuer’s board of directors (or persons performing the equivalent functions):
|
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer’s ability to record, process, summarize and report financial information; and
|
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer’s internal control over financial reporting.
|
/s/ Kurt L. Kalbfleisch
|
Kurt L. Kalbfleisch
|
Senior Vice-President and
|
Chief Financial Officer
|
•
|
|
The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
|
•
|
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
|
/s/ Peter Tassiopoulos
|
Peter Tassiopoulos
|
Chief Executive Officer
|
•
|
|
The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
|
•
|
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ Kurt L. Kalbfleisch
|
Kurt L. Kalbfleisch
|
Senior Vice-President and
|
Chief Financial Officer
|